Cost-Utility Analysis of Drug Treatments in Patients with Polypoidal Choroidal Vasculopathy in Thailand
Sermsiri Sangroongruangsri,1 Usa Chaikledkaew,1,2 Prut Hanusaha,3 Tanapat Ratanapakorn,4 Paisan Ruamviboonsuk5 1Social and Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand; 2Mahidol University Health Technology Assessment (MUHTA) Gr...
Guardado en:
Autores principales: | Sangroongruangsri S, Chaikledkaew U, Hanusaha P, Ratanapakorn T, Ruamviboonsuk P |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/67b022bcc6ad4fccbb614ba25aaf8fef |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month outcomes in the Japanese cohort of EVEREST II study
por: Takahashi K, et al.
Publicado: (2018) -
Survey of Intravitreal Injection Techniques Among Retina Specialists in Mexico
por: Henaine-Berra A, et al.
Publicado: (2020) -
Polypoidal choroidal vasculopathy (PCV): the 4-year review of the real-life treatment experiences
por: Ratanasukon M, et al.
Publicado: (2018) -
Choroidal excavation with polypoidal choroidal vasculopathy: a case report
por: Kobayashi W, et al.
Publicado: (2012) -
Visual Outcomes and Prognostic Factors of Large Submacular Hemorrhages Secondary to Polypoidal Choroidal Vasculopathy
por: Matsuo Y, et al.
Publicado: (2021)